Author reply

We thank Hong et al for their interest in our recent study describing the characteristics of anterior segment herpes simplex in a large cohort of children. We are in complete agreement that data generated from randomized clinical trials are desirable. However, logistical issues and cost often preclude randomized trials for medications that are already approved for use. In the absence of level 1 evidence, large case series such as our study do provide a reasonable starting point to guide clinical care. We also agree that definitive diagnosis of herpes simplex (Read more...)

Full Story →